E. Akdaş Et Al. , "Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab," Allergologia et Immunopathologia , vol.52, no.3, pp.1-7, 2024
Akdaş, E. Et Al. 2024. Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab. Allergologia et Immunopathologia , vol.52, no.3 , 1-7.
Akdaş, E., GÜLEKON, A., Bulut, T. S. D., GÜLBAHAR, Ö., Öztürk, M., BAŞARAN, A. S., ... COŞAR, B.(2024). Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab. Allergologia et Immunopathologia , vol.52, no.3, 1-7.
Akdaş, Elçin Et Al. "Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab," Allergologia et Immunopathologia , vol.52, no.3, 1-7, 2024
Akdaş, Elçin Et Al. "Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab." Allergologia et Immunopathologia , vol.52, no.3, pp.1-7, 2024
Akdaş, E. Et Al. (2024) . "Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab." Allergologia et Immunopathologia , vol.52, no.3, pp.1-7.
@article{article, author={Elçin Akdaş Et Al. }, title={Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab}, journal={Allergologia et Immunopathologia}, year=2024, pages={1-7} }